BioAtla Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	111.47	215.51	244.98	238.61	3.7	Upgrade
Cash & Cash Equivalents	111.47	215.51	244.98	238.61	3.7	Upgrade
Cash Growth	-48.27%	-12.03%	2.67%	6341.82%	-65.90%	Upgrade
Other Current Assets	4.94	4.92	2.31	2.08	0.8	Upgrade
Total Current Assets	116.41	220.43	247.29	240.68	4.51	Upgrade
Property, Plant & Equipment	3.1	5.15	6.98	4.1	4.68	Upgrade
Other Long-Term Assets	0.15	0.15	0.15	0.15	0.15	Upgrade
Total Long-Term Assets	3.25	5.31	7.13	4.26	4.83	Upgrade
Total Assets	119.66	225.74	254.42	244.94	9.34	Upgrade
Accounts Payable	26.72	21.61	18.42	12.07	11.97	Upgrade
Deferred Revenue	0	0	0	21.82	22.42	Upgrade
Current Debt	1.62	1.52	1.39	0	9.71	Upgrade
Other Current Liabilities	0	0	0	-1.63	-17.38	Upgrade
Total Current Liabilities	28.34	23.13	19.81	32.26	26.72	Upgrade
Long-Term Debt	0.84	2.46	3.98	0.68	8.41	Upgrade
Other Long-Term Liabilities	19.81	19.81	19.81	2.02	30.22	Upgrade
Total Long-Term Liabilities	20.64	22.27	23.79	2.7	38.63	Upgrade
Total Liabilities	48.99	45.4	43.6	34.96	65.35	Upgrade
Total Debt	2.46	3.98	5.37	0.68	18.12	Upgrade
Debt Growth	-38.21%	-25.88%	687.54%	-96.24%	20.80%	Upgrade
Retained Earnings	-416.26	-292.8	-186.32	-90.92	-148.35	Upgrade
Shareholders' Equity	70.67	180.34	210.82	209.97	-55.96	Upgrade
Net Cash / Debt	109.01	211.53	239.61	237.92	-14.42	Upgrade
Net Cash / Debt Growth	-48.46%	-11.72%	0.71%	-	-	Upgrade
Net Cash Per Share	2.28	5.43	6.93	28.23	-0.26	Upgrade
Working Capital	88.06	197.3	227.48	208.42	-22.21	Upgrade
Book Value Per Share	1.48	4.63	6.10	24.91	-1.02	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).